Bortezomib in a phase 1 trial for patients with relapsed AL amyloidosis: cardiac responses and overall effects.
Saved in:
| Title: | Bortezomib in a phase 1 trial for patients with relapsed AL amyloidosis: cardiac responses and overall effects. |
|---|---|
| Authors: | Dubrey, S.W.1, Reece, D.E.1, Sanchorawala, V.1, Hegenbart, U.1, Merlini, G.1, Palladini, G.1, Fermand, J.-P.1, Vescio, R.A.1, Bladé, J.1, Heffner, L.T.1, Hassoun, H.1, Liu, X.1, Enny, C.1, Ramaswami, P.1, Elsayed, Y.1, Van De Velde, H.1, Mortimer, S.1, Cakana, A.1, Comenzo, R.L.1 |
| Source: | QJM: An International Journal of Medicine. Nov2011, Vol. 104 Issue 11, p957-970. 14p. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
